The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

MOVIPREP, powder for oral solution

Lexon Pharmaceuticals (Ireland) LimitedPPA23176/034/001

Main Information

Trade NameMOVIPREP, powder for oral solution
Active SubstancesMacrogol 3350
Sodium sulphate anhydrous
Sodium chloride
Potassium chloride
Ascorbic acid
Sodium ascorbate
Dosage FormPowder for oral solution
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/034/001

Group Information

ATC CodeA06AD Osmotically acting laxatives
A06AD65 macrogol, combinations


License statusAuthorised
Licence Issued16/10/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back